Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hye Ji Lim"'
Autor:
Na Kyung Lee, Woong Bi Jang, Dong Sik Seo, Hui‐Gwan Goo, Hye ji Lim, Eun Ji Lee, Sang-Mo Kwon
Publikováno v:
Stem Cell Research, Vol 79, Iss , Pp 103476- (2024)
Cardiovascular disease remains a global health concern. Stem cell therapy utilizing human cardiac progenitor cells (hCPCs) shows promise in treating cardiac vascular disease. However, limited availability and senescence of hCPCs hinder their widespre
Externí odkaz:
https://doaj.org/article/00144adbc6db4f8187a71e48bf5b4d2a
Autor:
Ji Hye Park, Na Kyoung Lee, Hye Ji Lim, Seung taek Ji, Yeon-Ju Kim, Woong Bi Jang, Da Yeon Kim, Songhwa Kang, Jisoo Yun, Jong seong Ha, Hyungtae Kim, Dongjun Lee, Sang Hong Baek, Sang-Mo Kwon
Publikováno v:
Experimental and Molecular Medicine, Vol 55, Iss 11, Pp 2473-2473 (2023)
Externí odkaz:
https://doaj.org/article/aad4019c80834035a4d7d7661aadd2b8
Autor:
Hye Ji Lim, Woong Bi Jang, Vinoth Kumar Rethineswaran, Jaewoo Choi, Eun Ji Lee, Sangmi Park, Yeoreum Jeong, Jong Seong Ha, Jisoo Yun, Young Jin Choi, Young Joon Hong, Sang-Mo Kwon
Publikováno v:
Cells, Vol 12, Iss 15, p 2005 (2023)
Endothelial progenitor cell (EPC)-based stem cell therapy is a promising therapeutic strategy for vascular diseases. However, continuous in vitro expansion for clinical studies induces the loss of EPC functionality due to aging. In this study, we inv
Externí odkaz:
https://doaj.org/article/3b553cc0f0a749088b7a382c5000d711
Autor:
Ji Hye Park, Na Kyoung Lee, Hye Ji Lim, Seung taek Ji, Yeon-Ju Kim, Woong Bi Jang, Da Yeon Kim, Songhwa Kang, Jisoo Yun, Jong seong Ha, Hyungtae Kim, Dongjun Lee, Sang Hong Baek, Sang-Mo Kwon
Publikováno v:
Experimental and Molecular Medicine, Vol 52, Iss 4, Pp 615-628 (2020)
Abstract The mammalian target of rapamycin (mTOR) signaling pathway efficiently regulates the energy state of cells and maintains tissue homeostasis. Dysregulation of the mTOR pathway has been implicated in several human diseases. Rapamycin is a spec
Externí odkaz:
https://doaj.org/article/4a2be8058e2b4f1bbd3d0a9b1438cf64
Autor:
Ji Hye Park, Na-Kyung Lee, Hye Ji Lim, Sinthia Mazumder, Vinoth Kumar Rethineswaran, Yeon-Ju Kim, Woong Bi Jang, Seung Taek Ji, Songhwa Kang, Da Yeon Kim, Le Thi Hong Van, Ly Thanh Truong Giang, Dong Hwan Kim, Jong Seong Ha, Jisoo Yun, Hyungtae Kim, Jin Han, Natalia P. Mishchenko, Sergey A. Fedoreyev, Elena A. Vasileva, Sang Mo Kwon, Sang Hong Baek
Publikováno v:
Marine Drugs, Vol 17, Iss 6, p 368 (2019)
Cardiac progenitor cells (CPCs) are resident stem cells present in a small portion of ischemic hearts and function in repairing the damaged heart tissue. Intense oxidative stress impairs cell metabolism thereby decreasing cell viability. Protecting C
Externí odkaz:
https://doaj.org/article/0ca9bd2924534606b56743ee68fe9bbf
Autor:
Da Yeon Kim, Sangmi Park, Jisoo Yun, Woongbi Jang, Vinoth Kumar Rethineswaran, Le Thi Hong Van, Ly Thanh Truong Giang, Jaewoo Choi, Hye ji Lim, Sang-Mo Kwon
Publikováno v:
Molecular & Cellular Toxicology. 19:311-319
Autor:
Vinothkumar Rethineswaran, Woong Bi Jang, Jaewoo Choi, Hye Ji Lim, Sangmi Park, Eun Ji Lee, Jong Seong Ha, Jisoo Yun, Sang-Mo Kwon
Mitochondria are intracellular organelles that regulate cell survival and death, and hyperglycemia modulates mitochondrial function in endothelial cells. In the current study, we have discovered that high glucose (HG) treatment reduces FUNDC1 (FUN14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cddc922f72c65054f2fbfd0de991b9a
https://doi.org/10.21203/rs.3.rs-2903880/v1
https://doi.org/10.21203/rs.3.rs-2903880/v1
Autor:
Eun Ji Lee, Woong Bi Jang, Jaewoo Choi, Hye ji Lim, Sangmi Park, Vinoth Kumar Rethineswaran, Jong Seong Ha, Jisoo Yun, Young Joon Hong, Sang-Mo Kwon
Cardiotoxicity caused by doxorubicin (DOX) is an important issue to consider for both patients and doctors who require DOX. DOX-induced cardiotoxicity is closely associated with cardiomyocyte death and dysfunction. To prevent DOX-induced cardiotoxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bab770a2cc2f918cc941fe72b3cfa38b
https://doi.org/10.21203/rs.3.rs-2519611/v1
https://doi.org/10.21203/rs.3.rs-2519611/v1
Autor:
Ji Hye Park, Hyeok Kim, Hyung Ryong Moon, Bong-Woo Park, Jae-Hyun Park, Woo-Sup Sim, Jin-Ju Kim, Hye Ji Lim, Yeon-Ju Kim, Seung Taek Ji, Woong Bi Jang, Vinoth Kumar Rethineswaran, Le Thi Hong Van, Ly Thanh Truong Giang, Jisoo Yun, Jong Seong Ha, Kiwon Ban, Hae Young Chung, Sang Hong Baek, Hun-Jun Park, Sang-Mo Kwon
Publikováno v:
Experimental & Molecular Medicine. 54:1061-1063
Autor:
Na-Kyung Lee, Jong Seong Ha, Thanh Truong Giang Ly, Jaewoo Choi, Sang Hong Baek, Dong Hwan Kim, Sang-Mo Kwon, Vinoth Kumar Rethineswaran, Da Yeon Kim, Songhwa Kang, Ji Hye Park, Jisoo Yun, Thi Hong Van Le, Jin Su Kim, Seung Taek Ji, Woong Bi Jang, Yeon-Ju Kim, Hye Ji Lim
Publikováno v:
Tissue Eng Regen Med
BACKGROUND: Despite promising advances in stem cell-based therapy, the treatment of ischemic cardiovascular diseases remains a big challenge due to both the insufficient in vivo viability of transplanted cells and poor angiogenic potential of stem ce